T. Coleman, et.al., COOH-terminal disruption of lipoprotein lipase in mice is lethal in homozygotes, but heterozygotes have elevated triglycerides and impaired enzyme activity., The Journal of biological chemistry, 1995, 270

http://rdf.ncbi.nlm.nih.gov/pubmed/7759497

T. Coleman, et.al., COOH-terminal disruption of lipoprotein lipase in mice is lethal in homozygotes, but heterozygotes have elevated triglycerides and impaired enzyme activity., The Journal of biological chemistry, 1995, 270

pubmed

allele

http://purl.org/net/cito/citesAsAuthority

• Lpl<tm1Sem>
  http://metadb.riken.jp/db/mgi_rdf/MGI:2429315

class

http://purl.org/net/cito/citesAsAuthority

• Lpl<tm1Sem>
  http://metadb.riken.jp/db/mgi_rdf/MGI:2429315

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• increased circulating cholesterol level_Lpl<tm1Sem>/Lpl<+>
  http://metadb.riken.jp/0005178I129P2OlaHsdC57BL6JLpltm1SemLplLplLpltm1Sem
• abnormal lipid homeostasis_Lpl<tm1Sem>/Lpl<+>
  http://metadb.riken.jp/0002118I129P2OlaHsdC57BL6JLpltm1SemLplLplLpltm1Sem
• increased circulating HDL cholesterol level_Lpl<tm1Sem>/Lpl<+>
  http://metadb.riken.jp/0001556I129P2OlaHsdC57BL6JLpltm1SemLplLplLpltm1Sem
• hyperlipidemia_Lpl<tm1Sem>/Lpl<tm1Sem>
  http://metadb.riken.jp/0001548I129P2OlaHsdC57BL6JLpltm1SemLpltm1SemLpltm1Sem
• atelectasis_Lpl<tm1Sem>/Lpl<tm1Sem>
  http://metadb.riken.jp/0001177I129P2OlaHsdC57BL6JLpltm1SemLpltm1SemLpltm1Sem
• decreased circulating HDL cholesterol level_Lpl<tm1Sem>/Lpl<tm1Sem>
  http://metadb.riken.jp/0000186I129P2OlaHsdC57BL6JLpltm1SemLpltm1SemLpltm1Sem
• pulmonary vascular congestion_Lpl<tm1Sem>/Lpl<tm1Sem>
  http://metadb.riken.jp/0010018I129P2OlaHsdC57BL6JLpltm1SemLpltm1SemLpltm1Sem
• increased circulating cholesterol level_Lpl<tm1Sem>/Lpl<tm1Sem>
  http://metadb.riken.jp/0005178I129P2OlaHsdC57BL6JLpltm1SemLpltm1SemLpltm1Sem
• increased circulating VLDL triglyceride level_Lpl<tm1Sem>/Lpl<+>
  http://metadb.riken.jp/0003975I129P2OlaHsdC57BL6JLpltm1SemLplLplLpltm1Sem
• neonatal lethality, complete penetrance_Lpl<tm1Sem>/Lpl<tm1Sem>
  http://metadb.riken.jp/0011087I129P2OlaHsdC57BL6JLpltm1SemLpltm1SemLpltm1Sem
• liver vascular congestion_Lpl<tm1Sem>/Lpl<tm1Sem>
  http://metadb.riken.jp/0010019I129P2OlaHsdC57BL6JLpltm1SemLpltm1SemLpltm1Sem
• increased circulating triglyceride level_Lpl<tm1Sem>/Lpl<tm1Sem>
  http://metadb.riken.jp/0001552I129P2OlaHsdC57BL6JLpltm1SemLpltm1SemLpltm1Sem
• increased circulating phospholipid level_Lpl<tm1Sem>/Lpl<+>
  http://metadb.riken.jp/0003980I129P2OlaHsdC57BL6JLpltm1SemLplLplLpltm1Sem
• increased circulating phospholipid level_Lpl<tm1Sem>/Lpl<tm1Sem>
  http://metadb.riken.jp/0003980I129P2OlaHsdC57BL6JLpltm1SemLpltm1SemLpltm1Sem
• increased circulating triglyceride level_Lpl<tm1Sem>/Lpl<+>
  http://metadb.riken.jp/0001552I129P2OlaHsdC57BL6JLpltm1SemLplLplLpltm1Sem